AtriCure, Inc.

Total Valuation

AtriCure, Inc. carries a market capitalization of 3.09B, placing it among publicly traded companies globally. Its enterprise value stands at 1.33B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

AtriCure, Inc. currently has 50.86M shares outstanding.

Valuation Ratios

AtriCure, Inc. trades at a trailing price-to-earnings ratio of 128.47. The price-to-sales ratio is 2.38, and the price-to-book ratio stands at 2.76.

Enterprise Valuation

On an enterprise value basis, AtriCure, Inc. trades at an EV/EBITDA multiple of 39.31 and an EV/FCF ratio of 16.04. The EV/Sales ratio of 2.33 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 102.90 provides insight into valuation relative to core operating earnings.

Financial Position

AtriCure, Inc. maintains a current ratio of 4.22, meaning it holds 4.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 13.76, indicating elevated leverage, while an interest coverage ratio of 5.99 demonstrates adequate ability to service its debt obligations.

Financial Efficiency

AtriCure, Inc. posts a return on equity of 2.15 and a return on invested capital of 1.99.

Taxes

Over the trailing twelve months, AtriCure, Inc. has paid 1.54M in income taxes, reflecting an effective tax rate of 12.75.

Stock Price Statistics

AtriCure, Inc.'s stock has gained approximately 68.38459% over the past 52 weeks. The 50-day moving average sits at 45.92, while the 200-day moving average is 35.76.

Income Statement

Over the trailing twelve months, AtriCure, Inc. generated 569.62M in revenue and converted that into 10.55M in net income, yielding earnings per share of 0.22. EBITDA reached 33.75M, while operating income came in at 12.89M.

Balance Sheet

AtriCure, Inc. holds 167.79M in cash and equivalents against 71.05M in total debt, resulting in a net debt position of -106.79M. Total book value stands at 516.43M, with working capital of 263.62M providing operational flexibility.

Cash Flow

AtriCure, Inc. produced 64.94M in operating cash flow over the past twelve months. After subtracting -12.82M in capital expenditures, free cash flow totaled 52.11M - equivalent to 1.08 per share.

Margins

AtriCure, Inc. operates with a gross margin of 76.30, reflecting its pricing power and cost economics. The operating margin of 2.26 and net profit margin of 1.85 provide insight into operational efficiency.

Dividends & Yields

Scores

AtriCure, Inc. posts an Altman Z-Score of 6.24, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.